We thank Drs Futyma and Kułakowski for their interest and insights regarding our case report and how it relates to the increasing utilization of bipolar ablation for challenging ventricular tachycardia (VT) substrates.

This case was one of the early bipolar ablations performed at our center and therefore our power utilization was conservative, with gradual up-titration after assessing for lack of complications at lower power. The long-term clinical control of the incessant unipolar-resistant VT, as well as the dramatic septal morphologic and wall motion changes noted on the postablation echocardiogram, demonstrate that the power utilized was sufficient.

Work by prominent electrophysiology groups[@bib1] has greatly advanced our translational science and clinical understanding of bipolar ablation for refractory VT. However, there remain gaps in our knowledge and we eagerly await further human studies to better delineate the optimal parameters for a given substrate/location.

With regard to utilization of bipolar ablation to target left ventricular summit VT, the letter authors have published elegant work demonstrating this technique. However, our group maintains a high level of caution with respect to bipolar ablation between the coronary veins or coronary cusps and adjacent endocardial sites. Given the limited translational data specifically looking at adjacent coronary artery damage with such a technique, it may be safer to consider wire mapping/coil embolization[@bib2] or alcohol ablation to a small arterial or venous branch[@bib3] to limit the risk of collateral damage to larger and more proximal coronary arteries.
